Abstract:Fucoxanthin, the most abundant but nearly untapped carotenoid resource, is in the spotlight in the last decade from various perspectives due to a wide range of bioactivities and healthy benefits. The exploitation of fucoxanthin for nutraceutical and pharmaceutical purposes encompasses enormous scientific and economic potentials. Traditional production of fucoxanthin from brown algae (macroalgae) is constrained by limited yield and prohibitively high cost. Microalgae, as the most diverse photoautotrophs, hold the promises as sustainable sources and ideal cell factories for commercial fucoxanthin production, owing to their rich fucoxanthin content and excellent biomass productivity. In this work, the recent progress in upstream (microalgae selection, optimization of culture conditions, trophic modes, cultivation strategies and biosynthesis pathway) as well as downstream processes (extraction) of fucoxanthin production has been comprehensively and critically reviewed. The major bottlenecks, such as screening of fucoxanthin-producers, conflict between biomass and fucoxanthin accumulation under high light condition, unclear steps in biosynthesis pathway and limited evaluation of outdoor scale-up cultivation and extraction, have been pinpointed. Most importantly, the applications of emerging and conventional techniques facilitating commercialization of microalgal fucoxanthin are highlighted. The reviewed and evaluated include breeding and high-throughput screening methods of elite strains; flashing light effect inducing concurrent biomass and fucoxanthin accumulation; fucoxanthin biosynthesis and the regulatory mechanisms associating with its accumulation elucidated with the development of genetic engineering and omics techniques; and photobioreactors, harvesting and extraction techniques suitable for scaling up fucoxanthin production. In conclusion, the prospects of microalgal fucoxanthin commercialization can be expected with the joint development of fundamental phycology and biotechnology.

Fucoxanthin from Marine Microalgae: A Promising Bioactive Compound for Industrial Production and Food Application.

A review on the progress, challenges and prospects in commercializing microalgal fucoxanthin

Fucoxanthin from Algae to Human, an Extraordinary Bioresource: Insights and Advances in up and Downstream Processes

Fucoxanthin Production of Microalgae under Different Culture Factors: A Systematic Review

Synthetic biology in microalgae towards fucoxanthin production for pharmacy and nutraceuticals

Progress on the biological characteristics and physiological activities of fucoxanthin produced by marine microalgae

Progress in the Preparation and Application of Fucoxanthin from Algae

Progress in Preparation and Application of Fucoxanthin from Marine Algae

Unlocking the Green Gold: Exploring the Cancer Treatment and the Other Therapeutic Potential of Fucoxanthin Derivatives from Microalgae

Valuable pigments from microalgae: phycobiliproteins, primary carotenoids, and fucoxanthin

Current advances in recovery and biorefinery of fucoxanthin from Phaeodactylum tricornutum

Fucoxanthin: A Promising Medicinal and Nutritional Ingredient

A Systematic Review on Marine Algae-Derived Fucoxanthin: An Update of Pharmacological Insights

A Potential Commercial Source of Fucoxanthin Extracted from the Microalga Phaeodactylum tricornutum

Meeting Sustainable Development Goals: Alternative Extraction Processes for Fucoxanthin in Algae

System metabolic tools reveal fucoxanthin metabolism in Nitzschia laevis for the improvement of fucoxanthin productivity

Delivery systems for fucoxanthin: Research progress, applications and future prospects

Highly Efficient Co-Production of Fucoxanthin and Eicosapentaenoic Acid by Heterotrophic Cultivation of a Newly Isolated Microalga Nitzschia Sp. FZU62

Advances in Studies on the Pharmacological Activities of Fucoxanthin

Fucoxanthin, a Marine Carotenoid Present in Brown Seaweeds and Diatoms: Metabolism and Bioactivities Relevant to Human Health

A systematic review of fucoxanthin as a promising bioactive compound in drug development